CD28 and B-cell chronic lymphocytic leukemia: Another trispecific, CC-312 (NCT06037018), targets CD19, CD3, and CD28, aiming to not only recruit T cells via CD3 but also deliver a potent co-stimulatory signal through CD28, improving the expansion and activity of T cells in CD19-positive CLL.